REFERENCES
- Coombs RW, Speck CE, Hughes JP, et al. Association between cultureable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. J Infect Dis. 1998;177: 320–330.
- Garcia-Bujalance S, Ruiz G, Landron de Guevara C, et al. Quantitation of human immunodeficiency virus type 1 RNA loads in cervicovaginal secretions in pregnant women and relationship between viral loads in the genital tract and blood. Eur J Clin Microbiol Infect Dis. 2004;23:111–115.
- Hart CE, Lennox JL, Pratt-Palmore M, et al. Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. J Infect Dis. 1999;179:871–882.
- Kovacs A, Chan LS, Chen Z, et al. HIV-1 RNA in plasma and genital tract secretions in women infected with HIV-1. J Acquir Immune Defic Syndr 1999;22:124–131.
- Filcher CD, Shugars DC, Fiscus SA, et al. HIV in body flu-ids during primary HIV infection: implications for pathogen-esis, treatment and public health. AIDS. 2001;15:837–845.
- Shaheen F,Sison AV, McIntosh L, Mukhtar M, Pomerantz RJ. Analysis of HIV-1 in the cervicovaginal secretions and blood of pregnant and nonpregnant women. J Hum Virol. 1999;2:154–166.
- Tachet A, Dulioust E, Salmon D, et al. Detection and quanti-fication of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission. AIDS. 1999;13:823–831.
- Cu-Uvin S, Caliendo AM, Reinert S, et al. Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA. AIDS. 2000;14:415–421.
- Debiaggi M, Zara F, Spinillo A, et al. Viral excretion in cervicovaginal secretions of HIV-1-infected women receiv-ing antiretroviral therapy. Eur J Clin Microbiol Infect Dis. 200120: 91–96.
- Fiore JR, Suligoi B, Saracino A, et al. Correlates of HIV-1 shedding in cervicovaginal secretions and effects of anti-retroviral therapies. AIDS. 2003;17:2169–2176.
- Taylor S, Pereira AS. Antiretroviral drug concentrations in the semen of HIV-1 infected men. Sex Transm Inf. 200177: 4–11.
- Si-Mohamed A, Kazatchkine MD, Heard I, et al. Selection of drug-resistant variants in the female genital tract of human immunodeficiency virus type-1-infected women receiving antiretroviral therapy. J Infect Dis. 2000;182: 112–122.
- Min SS, Corbett AH, Rezk N, et al. Protease inhibitor and nonnucleoside reverse transcriptase inhibitor concentra-tions in the genital tract of HIV-1-infected women. J Acquir Immune Defic Syndr 2004;37:1577–1580.
- Tribut O, Arvieux C, Michelet C, Chapplain JM, Allain H, Bentue-Ferrer D. Simultaneous quantitative assay of six HIV protease inhibitors, one metabolite, and two non-nucleoside reverse transcriptase inhibitors in human plasma by isocratic reversed-phase liquid chromatography. Ther Drug Montt. 2002;24:554–562.
- Baron P, Bremer J, Wasserman SS, et al. Detection and quantitation of human immunodeficiency virus type 1 in the female genital tract. The Division of AIDS Treatment Research Initiative 009 Study Group. J Clin Microbiol. 2000;38:3822–3824.
- Najjar AM, Lewis PF, Endeshaw Y, et al. Efficient isolation of human immunodeficiency virus type 1 RNA from cervi-cal swabs. J Clin MicrobioL 1998;36:2349–2352.
- John GC, Sheppard H, Mbori-Ngacha D, et al. Comparison of techniques for HIV-1 RNA detection and quantitation in cervicovaginal secretions. J Acquir Immune Defic Syndr. 2001;26:170–175.